CDKN2A and neoplasm: Moreover, upon dysfunction of pRB by oncogenic changes, E2F activates the Arf tumor suppressor gene to link the RB pathway to the p53 pathway, two major pathways for tumor suppression, thereby playing a crucial role in the suppression of tumorigenesis against oncogenic changes.